All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Adele and Ozempic: What Her Interviews Actually Say

Adele rejected Sirtfood Diet and Pilates claims in her 2021 Vogue interviews. Compare her actual account with unsupported medication assumptions.

By FormBlends Editorial Research||
Adele public figure photo for Adele and Ozempic: What Her Interviews Actually Say
Adele. Image credit: Marc E.; license: CC BY 2.0.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Direct answer: Adele's own account does not support the Sirtfood Diet and Pilates explanation previously published here. In her British Vogue interview for the November 2021 issue, she rejected the Sirtfood Diet and intermittent fasting claims and described working with trainers. The interview establishes what she said about that period. It does not establish a current medication history or an explicit Ozempic denial.

See your GLP-1 options in about 2 minutes. Free and private. See my options →

What Adele actually said in the 2021 interviews

The original British Vogue interview, now presented as an archive feature, is the relevant source for the diet question. The separate American Vogue profile discusses her strength training and the role exercise played in managing anxiety. Neither source justifies estimating her starting weight from photographs.

ClaimSource recordEditorial outcome
Adele used the Sirtfood DietShe rejected that explanation in British Vogue.Do not attribute this diet to her.
She credited a Pilates instructorShe disputed claims made by a Pilates instructor she said she had never met.Do not present Pilates as her verified explanation.
She discussed exerciseBoth Vogue interviews describe training.Attribute this account to Adele and its interview date.
She denied Ozempic in those interviewsThe reviewed passages do not establish that statement.A diet denial is not a medication denial.

A timeline cannot identify a medication

The fact that an appearance change preceded widespread public discussion of a drug does not prove that the drug was unavailable or unused. Conversely, a later photograph does not supply a prescription record. Those are separate propositions, and neither follows from a celebrity timeline.

The previous article estimated Adele's starting weight from photographs, converted a reported change into a body-weight percentage and compared it with drug-trial averages. That calculation had no verified starting measurement. A numerical result built on an inferred starting weight cannot settle the medication question.

FAQ: Questions about Adele's account

Did Adele say she used the Sirtfood Diet?

No. The British Vogue interview records her rejection of that claim.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Does her training account prove she never used medication?

No. It establishes the activities she discussed, rather than an exhaustive medication history.

Can her photographs establish how much weight she lost?

A photograph supplies no measured starting or ending weight. Any numerical account should be attributed to its actual source, not estimated from appearance.

Sources

Platform Disclaimer. FormBlends connects eligible patients with U.S.-licensed providers and pharmacies. We do not provide direct clinical care, do not prescribe, and do not dispense medications. All clinical decisions are made by independent providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved formulations. They are produced by state-licensed 503A compounding pharmacies in response to individual prescriptions. They are not equivalent to brand Wegovy or Zepbound and have not undergone the FDA new-drug approval pathway.

Results Disclaimer. Individual results vary substantially. Adele's reported 100-pound loss reflects her individual case over approximately two years, with the resources and structure available to her. The result is not predictive for individuals pursuing similar protocols without similar resources.

Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly. British Vogue is a registered trademark of Condé Nast. "Adele One Night Only" is a registered work of CBS / Paramount. The Sirtfood Diet is associated with Aidan Goggins and Glen Matten. FormBlends is not affiliated with, endorsed by, or sponsored by Adele, Condé Nast, CBS, Oprah Winfrey, Novo Nordisk, Eli Lilly, or any other party referenced in this article.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Research Snapshot

Medication guide

Entities covered

Page type
Medication guide
Page metadata
Page updated
2026-10-02
Page metadata
Ozempic official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-10-02.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Adele and Ozempic: What Her Interviews Actually Say research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

GLP-1 Weight Loss

Did Lizzo Use Ozempic? What She Actually Said, the Timeline of Her Weight Loss, and What the Speculation Reveals About GLP-1 Stigma

Lizzo denied using Ozempic in September 2023. What she actually said, the timeline of her weight loss, and why the speculation reveals broader issues.

GLP-1 Weight Loss

What "Kylie Jenner Ozempic Face" Actually Reveals About GLP-1 Facial Volume Loss (and Why the Speculation Misses the Point)

Why GLP-1 medications cause facial volume loss, the biological mechanism behind "Ozempic face," and what the Kylie Jenner speculation gets wrong.

GLP-1 Weight Loss

Can a 16-Year-Old Take Ozempic for Weight Loss? The FDA Approval Gap and What's Actually Legal

The FDA-approved age limits for Ozempic in teens, why off-label pediatric use is controversial, and the approved GLP-1 alternatives for adolescents.

GLP-1 Weight Loss

Can Anyone Take Ozempic? FDA Approvals, Off-Label Use, and Who Actually Qualifies

Who can legally take Ozempic: FDA-approved uses vs off-label prescribing, BMI thresholds, contraindications, and the criteria providers actually use.

GLP-1 Weight Loss

Can Ozempic Cause Anxiety? Understanding the GLP-1 Psychiatric Signal and What the Data Actually Shows

Ozempic and semaglutide show no anxiety signal in clinical trials, but individual reports exist. What causes them, when to worry, and how to respond.

GLP-1 Weight Loss

Can Ozempic Cause Blindness? The NAION Signal, What the Data Actually Shows, and When to Worry

The real risk of NAION (sudden vision loss) on Ozempic and other GLP-1s, who's actually at risk, and the monitoring protocol your provider should follow.

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.